Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01016756 · ClinicalTrials.gov registry record
Genetic Analysis of PHACE Syndrome (Hemangioma With Other Congenital Anomalies)
A clinical trial, sponsored by Medical College of Wisconsin.
- Completed
- Registry status
- 341
- Enrollment target
NCT01016756: Completed study, sponsored by Medical College of Wisconsin.
NCT01016756 is a clinical trial that has completed, run by Medical College of Wisconsin. The registered enrollment target is 341 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01016756 has completed, sponsored by Medical College of Wisconsin.
- COMPLETED
- Registry status
- 341 participants
- Enrollment target
Study Summary
1. PHACE syndrome(OMIM database number 606519) is the association of a vascular birthmark (hemangioma) on the face along with one or more of the following conditions: congenital heart defects, congenital anomalies of the cerebral arteries,brain, eyes, or sternum. 2. A research study is currently being conducted at the Medical College of Wisconsin (MCW) to investigate if there is an inherited cause of PHACE syndrome. 3. We are hoping that this study will lead to a better understanding of how and why children develop PHACE syndrome.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 341 participants |
| Start Date | 2007-02 |
| Est. Completion | 2022-08-15 |
What the finished NCT01016756 record still lists
NCT01016756 is an observational study that tracks outcomes without assigning an intervention. The registered 341 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01016756 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01016756 about?
NCT01016756 is a clinical study titled "Genetic Analysis of PHACE Syndrome (Hemangioma With Other Congenital Anomalies)". 1. PHACE syndrome(OMIM database number 606519) is the association of a vascular birthmark (hemangioma) on the face along with one or more of the following conditions: congenital heart defects, congenital anomalies of the cerebral arteries,brain, eyes, or sternum. 2. A research study is currently bei...
What is the current status of trial NCT01016756?
This trial is currently completed. The enrollment target is 341 participants. The study started on 2007-02. Estimated completion is 2022-08-15.
Who is sponsoring clinical trial NCT01016756?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06852170 · 341 participants · NA
Data2Action Oregon Project: Supporting Data-driven Decision-Making for Substance Use Services, Policy, and Overdose Prevention
- NCT05283850 · 342 participants · Phase 2
Surviving PEA in Roanoke (SPEAR) Study
- NCT05714085 · 342 participants · Phase 2
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
- NCT06188702 · 342 participants · Phase 1
S095035 as a Single Agent and in Combination in Adult Participants With Advanced or Metastatic Solid Tumors With Deletion of MTAP
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia